Tivic Net Income Per Share from 2010 to 2026
| TIVC Stock | USD 0.86 -0.09 -9.32% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -0.02 | Current Value -0.02 | Quarterly Volatility 74.15945526 |
Macro event markers
This statements view for Tivic Health organizes long-term performance signals with capital structure context. It connects Tax Provision of 800, Net Interest Income of 7.2 K or Depreciation And Amortization of 425 K and ratios such as Price To Sales Ratio of 2.1 K, Dividend Yield of 0.0 or PTB Ratio of 631 with Tivic Health Valuation and Volatility context.
Tivic | Net Income Per Share | Build AI portfolio with Tivic Stock |
Analyzing Tivic Health's Net Income Per Share over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income Per Share has evolved provides context for assessing Tivic Health's current valuation and future prospects.
Latest Tivic Health's Net Income Per Share Growth Pattern
Below is the plot of the Net Income Per Share of Tivic Health Systems over the last few years. It is Tivic Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tivic Health's overall financial position and show how it may be relating to other accounts over time.
| Net Income Per Share | 10 Years Trend |
|
Net Income Per Share |
| Timeline |
Tivic Net Income Per Share Regression Statistics
| Arithmetic Mean | -146.23 | |
| Coefficient Of Variation | -50.72 | |
| Mean Deviation | 56.53 | |
| Median | -180.36 | |
| Standard Deviation | 74.16 | |
| Sample Variance | 5,500 | |
| Range | 243 | |
| R-Value | 0.66 | |
| Mean Square Error | 3,297 | |
| R-Squared | 0.44 | |
| Significance | 0.0038 | |
| Slope | 9.72 | |
| Total Sum of Squares | 87,994 |
Tivic Net Income Per Share History
About Tivic Health Systems Inc
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California. Tivic Health operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 7 people. This overview emphasizes how Tivic Health compares to peers on valuation quality and operating consistency. Current metrics include P/B of 0.42. Tivic Health has market cap of 2.41 M, ROE of -1.78%.
Methodology
Unless otherwise specified, financial data for Tivic Health Systems is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Tivic (USA Stocks:TIVC) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs rely on public filings and market reference sources and institutional disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Publication cadence can introduce timing differences. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Tivic Health Systems may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.More Resources for Tivic Stock Analysis
A structured review of Tivic Health Systems often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Key reports that frame Tivic Health Systems Stock are listed below:Compare Tivic Health against competitors using Tivic Health Correlation. This provides competitive positioning context. Analysis related to Tivic Health should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Earnings Share -8.00 | Revenue Per Share | Quarterly Revenue Growth 0.159 | Return On Assets | Return On Equity |
Investors evaluate Tivic Health Systems using market value and book value, each describing different facets of the business. Tivic Health's market capitalization is 2.41 M. A P/B ratio of 0.42 suggests Tivic Health trades near or below book value. Enterprise value stands at 355.06 K. Intrinsic value is an analytical estimate of Tivic Health's underlying worth that can differ from price and book value. Valuation methods help interpret those gaps.
Value and price for Tivic Health are related but not identical, and they can diverge across cycles. For Tivic Health, key inputs include a P/B ratio of 0.42, ROE of -1.78%, and revenue of 780 K. Trading price represents the transaction level agreed by market participants.